MoneyWorks4Me

Venmax Drugs And Pharmaceuticals informs about financial results

15 Nov 2018 Evaluate

In compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Venmax Drugs And Pharmaceuticals has informed about the un-audited Financial Results of the company for the 2nd and half year ended September 30, 2018, as approved by the Board of Director at their meeting held today i.e. 14th November, 2018 at 4.00 P M and concluded at 4.45 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..